{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:16:46Z","timestamp":1793798206765,"version":"4.6.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.metabol.2015.10.014","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T11:18:00Z","timestamp":1444821480000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":573,"title":["Metformin-associated lactic acidosis: Current perspectives on causes and risk"],"prefix":"10.1016","volume":"65","author":[{"given":"Ralph","family":"DeFronzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alexander","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Bicsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.10.014_bb0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9343(96)00353-1","article-title":"An overview of metformin in the treatment of type 2 diabetes mellitus","volume":"102","author":"Davidson","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2015.10.014_bb0020","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142012","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/dia.2014.0203","article-title":"Helicobacter pylori infection decreases metformin tolerance in patients with type 2 diabetes mellitus","volume":"17","author":"Huang","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.metabol.2015.10.014_bb0030","series-title":"Glucophage (metformin hydrochloride) and Glucophage XR (extended-release) prescribing information","year":"2009"},{"key":"10.1016\/j.metabol.2015.10.014_bb0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/diacare.15.6.755","article-title":"Biguanides and NIDDM","volume":"15","author":"Bailey","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0040","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/cc7137","article-title":"Metformin-associated lactic acidosis in an intensive care unit","volume":"12","author":"Peters","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lactic acidosis in patients with diabetes treated with metformin","volume":"338","author":"Misbin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5301\/jn.5000166","article-title":"Metformin in patients with chronic kidney disease: strengths and weaknesses","volume":"26","author":"Rocha","year":"2013","journal-title":"J Nephrol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0055","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.2337\/dc13-3023","article-title":"Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study","volume":"37","author":"Eppenga","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0060","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc14-0464","article-title":"Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study","volume":"37","author":"Richy","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group","volume":"333","author":"DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01263446","article-title":"Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas","volume":"14","author":"Waters","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.10.014_bb0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0026-0495(97)90307-3","article-title":"Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients","volume":"46","author":"Fery","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.10.014_bb0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1464-5491.1999.00006.x","article-title":"Metformin-associated lactic acidosis: a rare or very rare clinical entity?","volume":"16","author":"Chan","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0085","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/mol.63.4.844","article-title":"Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin","volume":"63","author":"Wang","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0090","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.10.014_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2015.10.014_bb0100","article-title":"Unexpectedly long half-life of metformin elimination in cases of metformin accumulation","author":"Kajbaf","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1752-1947-8-159","article-title":"Metformin-associated lactic acidosis presenting as an ischemic gut in a patient who then survived a cardiac arrest: a case report","volume":"8","author":"Ncomanzi","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.metabol.2015.10.014_bb0110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jcpt.12187","article-title":"Pharmacist review prevents evolving metformin-associated lactic acidosis","volume":"39","author":"Naunton","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.metabol.2015.10.014_bb0115","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.diabres.2013.12.055","article-title":"Acute renal failure and metformin-associated lactic acidosis following colonoscopy","volume":"105","author":"Hussain","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2015.10.014_bb0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3803\/EnM.2015.30.1.78","article-title":"Metformin-associated lactic acidosis: predisposing factors and outcome","volume":"30","author":"Kim","year":"2015","journal-title":"Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.10.014_bb0125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20140620","article-title":"Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria","volume":"462","author":"Bridges","year":"2014","journal-title":"Biochem J"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2015.10.014_bb0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2015.10.014_bb0135","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/ndt\/gfn152","article-title":"Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice","volume":"23","author":"Almirall","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2015.10.014_bb0140","first-page":"24","article-title":"The status of metformin in Canada","volume":"128","author":"Lucis","year":"1983","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.metabol.2015.10.014_bb0145","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2337\/dc09-1284","article-title":"Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations","volume":"33","author":"Frid","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJMcpc1208154","article-title":"Case records of the Massachusetts General Hospital. Case 23-2013. A 54-year-old woman with abdominal pain, vomiting, and confusion","volume":"369","author":"Kalantar-Zadeh","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1463-1326.2001.00128.x","article-title":"Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis'","volume":"3","author":"Lalau","year":"2001","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2015.10.014_bb0160","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11255-010-9845-1","article-title":"Metformin-related lactic acidosis in patients with acute kidney injury","volume":"43","author":"Devetzis","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1752-1947-1-126","article-title":"Metformin-induced lactic acidosis: a case series","volume":"1","author":"Silvestre","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.metabol.2015.10.014_bb0170","first-page":"185","article-title":"Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment","volume":"66","author":"Bruijstens","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0175","doi-asserted-by":"crossref","first-page":"e23200","DOI":"10.1371\/journal.pone.0023200","article-title":"Management of metformin-associated lactic acidosis by continuous renal replacement therapy","volume":"6","author":"Keller","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.10.014_bb0180","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1464-5491.2005.01650.x","article-title":"Fulminant lactic acidosis in two patients with type 2 diabetes treated with metformin","volume":"22","author":"Brassoe","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5414\/CP201728","article-title":"Monitoring of metformin-induced lactic acidosis in a diabetic patient with acute kidney failure and effect of hemodialysis","volume":"51","author":"Laforest","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.metabol.2015.10.014_bb0190","doi-asserted-by":"crossref","first-page":"b3660","DOI":"10.1136\/bmj.b3660","article-title":"Metformin associated lactic acidosis","volume":"339","author":"Fitzgerald","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2015.10.014_bb0195","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2337\/dc10-2140","article-title":"Effect of gastric bypass surgery on the absorption and bioavailability of metformin","volume":"34","author":"Padwal","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0200","doi-asserted-by":"crossref","first-page":"196","DOI":"10.20344\/amp.4071","article-title":"Relation between metformin treatment and the development of hyperlactacidemia at the emergency room","volume":"27","author":"Guelho","year":"2014","journal-title":"Acta Med Port"},{"key":"10.1016\/j.metabol.2015.10.014_bb0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin - mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0210","first-page":"31","article-title":"Metformin-induced lactic acidosis with emphasis on the anion gap","volume":"28","author":"Blough","year":"2015","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.metabol.2015.10.014_bb0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1752-1947-8-449","article-title":"Metformin-associated lactic acidosis and temporary ileostomy: a case report","volume":"8","author":"Margiani","year":"2014","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.metabol.2015.10.014_bb0220","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2796.2003.01271.x","article-title":"Metformin and lactic acidosis: cause or coincidence? A review of case reports","volume":"255","author":"Stades","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0225","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002018-199920040-00006","article-title":"Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations","volume":"20","author":"Lalau","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.metabol.2015.10.014_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2050-6511-14-22","article-title":"The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis","volume":"14","author":"Kajbaf","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0235","doi-asserted-by":"crossref","first-page":"717198","DOI":"10.1155\/2014\/717198","article-title":"Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels","volume":"2014","author":"Lalau","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0240","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/cc9404","article-title":"Metformin-induced lactic acidosis: no one left behind","volume":"15","author":"Vecchio","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MJT.0b013e318197eab6","article-title":"The MALAdy of metformin poisoning: is CVVH the cure?","volume":"17","author":"Arroyo","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.metabol.2015.10.014_bb0250","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/CCM.0b013e3181a02490","article-title":"Metformin-associated lactic acidosis: a prognostic and therapeutic study","volume":"37","author":"Seidowsky","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0255","doi-asserted-by":"crossref","first-page":"R226","DOI":"10.1186\/cc9376","article-title":"Outcome of severe lactic acidosis associated with metformin accumulation","volume":"14","author":"Friesecke","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0265","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/j.1552-4604.1995.tb04033.x","article-title":"Kidney function and age are both predictors of pharmacokinetics of metformin","volume":"35","author":"Sambol","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0270","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2337\/diacare.27.7.1791","article-title":"The phantom of lactic acidosis due to metformin in patients with diabetes","volume":"27","author":"Misbin","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0275","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiol.09090690","article-title":"Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin","volume":"254","author":"Goergen","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.metabol.2015.10.014_bb0280","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archinte.162.4.434","article-title":"Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy","volume":"162","author":"Calabrese","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0285","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1001\/jama.287.19.2504-a","article-title":"Frequency of inappropriate metformin prescriptions","volume":"287","author":"Horlen","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2015.10.014_bb0290","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1464-5491.2001.00509.x","article-title":"Contraindications to metformin therapy in patients with type 2 diabetes\u2014a population-based study of adherence to prescribing guidelines","volume":"18","author":"Emslie-Smith","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2015.06.001","article-title":"Adverse event notifications implicating metformin with lactic acidosis in Australia","author":"Huang","year":"2015","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.metabol.2015.10.014_bb0300","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11096-007-9095-1","article-title":"Contraindications to metformin therapy among patients with type 2 diabetes mellitus","volume":"29","author":"Sweileh","year":"2007","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.metabol.2015.10.014_bb0305","series-title":"NICE Guidelines [CG87]","article-title":"Type 2 diabetes: the management of type 2 diabetes","year":"2009"},{"key":"10.1016\/j.metabol.2015.10.014_bb0310","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.metabol.2015.10.014_bb0315","doi-asserted-by":"crossref","first-page":"e001076","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Ekstr\u00f6m","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.metabol.2015.10.014_bb0320","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc10-2361","article-title":"Use of metformin in the setting of mild-to-moderate renal insufficiency","volume":"34","author":"Lipska","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0325","series-title":"Danish Health and Medicines Authority Pharmacovigilance Update #9","article-title":"Cases of lactic acidosis in patients undergoing treatment with metformin for the treatment of type 2 diabetes","year":"2012"},{"key":"10.1016\/j.metabol.2015.10.014_bb0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11096-015-0097-0","article-title":"Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients","volume":"37","author":"Hanatani","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.metabol.2015.10.014_bb0335","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0340","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2213-8587(15)00133-3","article-title":"Metformin in chronic kidney disease: more harm than help?","volume":"3","author":"Kalantar-Zadeh","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0345","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrneph.2015.110","article-title":"Chronic kidney disease: metformin increases risk of mortality in patients with advanced chronic kidney disease","volume":"11","author":"Edwards","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0350","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/dme.12515","article-title":"A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure","volume":"31","author":"Adam","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/dme.12626","article-title":"Comment on 'A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure'","volume":"32","author":"Jones","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0360","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0365","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jemermed.2007.11.055","article-title":"Occult metformin toxicity in three patients with profound lactic acidosis","volume":"40","author":"Perrone","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0370","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1525-139X.2006.00123.x","article-title":"Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin","volume":"19","author":"Guo","year":"2006","journal-title":"Semin Dial"},{"key":"10.1016\/j.metabol.2015.10.014_bb0375","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1752-1947-6-230","article-title":"Lactic acidosis secondary to metformin overdose: a case report","volume":"6","author":"Timbrell","year":"2012","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.metabol.2015.10.014_bb0380","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jemermed.2007.09.034","article-title":"Metformin overdose with a resultant serum pH of 6.59: survival without sequalae","volume":"39","author":"Dell'Aglio","year":"2010","journal-title":"J Emerg Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0385","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1607-551X(09)70047-6","article-title":"Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose","volume":"25","author":"Yang","year":"2009","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.metabol.2015.10.014_bb0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bja\/ael347","article-title":"Severe lactic acidosis and rhabdomyolysis following metformin and ramipril overdose","volume":"98","author":"Galea","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.metabol.2015.10.014_bb0395","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/ndt\/gfh337","article-title":"Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis","volume":"19","author":"Panzer","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2015.10.014_bb0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1081\/JDI-120013973","article-title":"High anion gap metabolic acidosis in suicide: don't forget metformin intoxication\u2014two patients' experiences","volume":"24","author":"Chang","year":"2002","journal-title":"Ren Fail"},{"key":"10.1016\/j.metabol.2015.10.014_bb0405","first-page":"160","article-title":"Fatal metformin overdose presenting with progressive hyperglycemia","volume":"9","author":"Suchard","year":"2008","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2004-817931","article-title":"Experiences of a poison center with metformin-associated lactic acidosis","volume":"112","author":"von Mach","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2015.10.014_bb0415","first-page":"664","article-title":"The importance of early haemodiafiltration in the treatment of lactic acidosis associated with the administration of metformin","volume":"32","author":"Baro-Serra","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.metabol.2015.10.014_bb0420","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ndt\/12.5.1046","article-title":"Bicarbonate haemodialysis as a treatment of metformin overdose","volume":"12","author":"Heaney","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.metabol.2015.10.014_bb0425","article-title":"Metformin-associated lactic acidosis following intentional overdose successfully treated with tris-hydroxymethyl aminomethand and renal replacement therapy. Case Reports in","volume":"2012","author":"Lam","year":"2012","journal-title":"Nephrology"},{"key":"10.1016\/j.metabol.2015.10.014_bb0430","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/01.PCC.0000162451.47034.4F","article-title":"Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization","volume":"6","author":"Harvey","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0435","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.28.3.539","article-title":"Comparative outcomes study of metformin intervention versus conventional approach the COSMIC Approach Study","volume":"28","author":"Cryer","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0440","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.metabol.2015.10.014_bb0445","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc08-1171","article-title":"Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case\u2013control analysis","volume":"31","author":"Bodmer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/ACPJC-2004-141-1-007","article-title":"Review: metformin does not increase risk for lactic acidosis or increase lactate levels in type 2 diabetes","volume":"141","author":"Kruse","year":"2004","journal-title":"ACP J Club"},{"key":"10.1016\/j.metabol.2015.10.014_bb0455","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0885066605278644","article-title":"Lactic acidosis: from sour milk to septic shock","volume":"20","author":"Fall","year":"2005","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0460","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0889-8529(18)30163-4","article-title":"Lactic acidosis","volume":"22","author":"Stacpoole","year":"1993","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.metabol.2015.10.014_bb0465","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/cc1518","article-title":"Bench-to-bedside review: lactate and the kidney","volume":"6","author":"Bellomo","year":"2002","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0470","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/bj2190073","article-title":"The influence of renal function on lactate and glucose metabolism","volume":"219","author":"Bartlett","year":"1984","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2015.10.014_bb0475","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2015.10.014_bb0480","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/0091270008316884","article-title":"Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus","volume":"48","author":"Hong","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0485","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diacare.18.6.779","article-title":"Role of metformin accumulation in metformin-associated lactic acidosis","volume":"18","author":"Lalau","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0490","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/clpt.1987.55","article-title":"Plasma biguanide levels are correlated with metabolic effects in diabetic patients","volume":"41","author":"Marchetti","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.metabol.2015.10.014_bb0495","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/14746514010010010501","article-title":"Review: optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes","volume":"1","author":"Scarpello","year":"2001","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/j.metabol.2015.10.014_bb0500","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.0306-5251.2001.01423.x","article-title":"The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: the Fremantle Diabetes Study","volume":"52","author":"Davis","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0505","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2337\/dc10-2207","article-title":"Metformin and exercise in type 2 diabetes: examining treatment modality interactions","volume":"34","author":"Boul\u00e9","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0510","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1463-1326.2006.00690.x","article-title":"Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide","volume":"10","author":"Cunha","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2015.10.014_bb0515","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0520","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/cc8885","article-title":"Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication","volume":"14","author":"Protti","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.metabol.2015.10.014_bb0525","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.53.4.1052","article-title":"Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?","volume":"53","author":"Brunmair","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.10.014_bb0530","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.200710-1602OC","article-title":"Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury","volume":"178","author":"Zmijewski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.metabol.2015.10.014_bb0535","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1074\/jbc.275.1.223","article-title":"Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I","volume":"275","author":"El-Mir","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.10.014_bb0540","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/15563650.2013.784774","article-title":"Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs","volume":"51","author":"Al-Abri","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.metabol.2015.10.014_bb0545","series-title":"75th Scientific Sessions of the American Diabetes Association. Boston, MA 2015","article-title":"metformin administration into the ileum is not associated with increased systemic lactate","author":"Chen","year":"2015"},{"key":"10.1016\/j.metabol.2015.10.014_bb0550","first-page":"549A","article-title":"Effects of new metformin formulation in stage 3 and 4 CKD: a pilot study","volume":"25","author":"Bakris","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2015.10.014_bb0555","first-page":"1087-P","article-title":"Dissociation between metformin plasma exposure and its glucose-lowering effect: a novel gut-mediated mechanism of action","author":"DeFronzo","year":"2013"},{"key":"10.1016\/j.metabol.2015.10.014_bb0560","article-title":"The primary glucose-lowering effect of metformin resides in the gut not the circulation. results from short-term pharmacokinetic and 12-week dose ranging studies","author":"Buse","year":"2015","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2016.05.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515003066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:08:05Z","timestamp":1758427685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515003066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0026049515003066"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.10.014","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin-associated lactic acidosis: Current perspectives on causes and risk","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}